August 24, 2011
The Raleigh-based drug firm gears to sell breakthrough cancer pain reliver after working through production problems.
October 20, 2010
The decision means $2.5 million in milestone payment for the Raleigh firm.
September 7, 2010
Benny Ward takes over as business and strategic development director at the drug delivery technology development firm.
May 10, 2010
The Raleigh-based firm can now sell its “breakthrough” pain killer drug outside of the U.S. It is seeking approval to sell Onsolis in Europe.
Updated April 20, 2010
The announced sale sends BDSI shares down 14 percent from Monday’s closing price of $4.21 per share.
September 2, 2009
Chief science officer is also leaving drug development firm, which recently won FDA approval for its first product.